Tacalyx

Tacalyx is a biotech company that focuses on the discovery and development of novel anti-TACA (tumor-associated carbohydrate antigens) cancer therapies. The company develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.